Cargando…

Clinical Cardiovascular Adverse Events Reported Post-COVID-19 Vaccination: Are They a Real Risk?

Given the urgent need to control the spread of the novel COVID-19 virus, 13 vaccines have been approved for emergency use before completing all 3 phases of the clinical trials. Thereby a careful monitor of the adverse effects postvaccination is essential. We searched through PubMed and other reporti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hana, David, Patel, Kevin, Roman, Sherif, Gattas, Boula, Sofka, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mosby-Year Book 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662957/ https://www.ncbi.nlm.nih.gov/pubmed/34902392 http://dx.doi.org/10.1016/j.cpcardiol.2021.101077

Ejemplares similares

Molecular methods in diagnostics of post-BCG vaccine adverse events
por: BRZEZIŃSKA, SYLWIA AGATA, et al.
Publicado: (2020)

Trials of testosterone replacement reporting cardiovascular adverse events
por: Gagliano-Jucá, Thiago, et al.
Publicado: (2018)

Adverse events with risankizumab in the real world: postmarketing pharmacovigilance assessment of the FDA adverse event reporting system
por: Shu, Yamin, et al.
Publicado: (2023)

Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 – October 2021
por: Moro, Pedro L., et al.
Publicado: (2022)

Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System
por: Jeon, Minji, et al.
Publicado: (2021)

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
por: Peluso, Rosario, et al.
Publicado: (2018)

Adverse Events and Safety Profile of the COVID-19 Vaccines in Adolescents: Safety Monitoring for Adverse Events Using Real-World Data
por: Lee, Chae Won, et al.
Publicado: (2022)

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

Prediabetes as a risk factor for major adverse cardiovascular events
por: Mando, Ramy, et al.
Publicado: (2021)

Adverse event reporting and Bell's palsy risk after COVID-19 vaccination
por: Chang, Kwok-Chiu, et al.
Publicado: (2021)

Adverse event reporting and Bell's palsy risk after COVID-19 vaccination
por: Khouri, Charles, et al.
Publicado: (2021)

Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database
por: Jeet Kaur, Rimple, et al.
Publicado: (2021)

Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
por: Duprey, Matthew S., et al.
Publicado: (2019)

Designing Adverse Event Forms for Real-World Reporting: Participatory Research in Uganda
por: Davies, Emma C., et al.
Publicado: (2012)

Age and Gender Disparities in Adverse Events Following COVID-19 Vaccination: Real-World Evidence Based on Big Data for Risk Management
por: Xiong, Xiaomo, et al.
Publicado: (2021)

Impact of Vaccination on Major Adverse Cardiovascular Events in Patients With COVID-19 Infection
por: Jiang, Joy, et al.
Publicado: (2023)

IMPACT OF VACCINATION ON MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG PATIENTS WITH COVID-19
por: Jiang, Joy, et al.
Publicado: (2023)

Cardiovascular Toxicity of Carfilzomib: The Real-World Evidence Based on the Adverse Event Reporting System Database of the FDA, the United States
por: Zhai, Yinghong, et al.
Publicado: (2021)

Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reports
por: Ewer, Michael S., et al.
Publicado: (2022)

1077 Adverse events following measles, mumps, and rubella (MMR) vaccine in adults reported to the Vaccine Adverse Event Reporting System, 2003-2013
por: Sukumaran, Lakshmi, et al.
Publicado: (2014)

TROPONIN-I PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AND RISK OF MORTALITY IN COVID-19 PATIENTS
por: Patel, Chirag, et al.
Publicado: (2021)

Glycaemic variability and risk of adverse cardiovascular events in acute coronary syndrome
por: Zhang, Lei, et al.
Publicado: (2022)

Risk factors for cardiovascular adverse events from immune checkpoint inhibitors
por: Luo, Lingli, et al.
Publicado: (2023)

Association of COVID-19 Outbreak with Changes in Physical Activity Among Adults with Elevated Risk for Major Adverse Cardiovascular Events
por: Waddell, Kimberly J., et al.
Publicado: (2021)

Manifestations of adverse events post Sinovac vaccine immunization at Wirasakti Hospital, Kupang
por: Basri, Aries Hasan, et al.
Publicado: (2023)

Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk Factors
por: Miao, Benjamin, et al.
Publicado: (2020)

Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
por: Liang, Yankun, et al.
Publicado: (2023)

Human papillomavirus vaccine-associated premature ovarian insufficiency and related adverse events: data mining of Vaccine Adverse Event Reporting System
por: Gong, Li, et al.
Publicado: (2020)

Comparison of the post-marketing safety profile between influenza and COVID-19 vaccines: An analysis of the vaccine adverse event reporting system
por: Al-Ahmari, Abdullah K., et al.
Publicado: (2022)

Summary of COVID-19 Vaccine-Related Reports in the Vaccine Adverse Event Reporting System
por: Ceacareanu, Alice C., et al.
Publicado: (2021)

Real‐world experience of carfilzomib‐associated cardiovascular adverse events: SEER‐Medicare data set analysis
por: Bishnoi, Rohit, et al.
Publicado: (2020)

Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real‐world evidence study
por: Chen, Guanmin, et al.
Publicado: (2021)

When vaccine adverse event reporting generates hope, not fear
por: Chang, Joyce C, et al.
Publicado: (2022)

COVID-19 vaccine adverse events reported via app
Publicado: (2021)

Reporting adverse events of COVID-19 vaccines: The case of Bulgaria
por: Rangelova, Vanya, et al.
Publicado: (2022)

Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case–control assessment of the vaccine adverse event reporting system (VAERS) database
por: Geier, David A., et al.
Publicado: (2016)

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2023)

The temporal relationship between RotaTeq immunization and intussusception adverse events in the Vaccine Adverse Event Reporting System (VAERS)
por: Geier, David A., et al.
Publicado: (2012)

Is the “July Effect” Real? Pediatric Trainee Reported Medical Errors and Adverse Events
por: Shah, Ankoor Y., et al.
Publicado: (2017)

Adverse event reporting and Bell's palsy risk after COVID-19 vaccination – Authors' reply
por: Wong, Ian Chi Kei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e404vv86dnoed9hvhiv68db95s